- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06455228
Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy
April 27, 2026 updated by: Sir Run Run Shaw Hospital
Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy: a Randomized Controlled Trial
This study applies long PIVCs to patients undergoing antimicrobial therapy, and compares the effects of different placement sites, aiming to provide a reference basis for patients undergoing antimicrobial treatment to select the optimal placement site, thus reducing complications, prolonging catheter retention time, and alleviating the patient's pain.
Study Overview
Detailed Description
This study investigates the use of long PIVCs in patients undergoing antimicrobial therapy, and compares the effects of different insertion sites.
The aim is to provide evidence-based recommendations for the optimal placement site for long PIVCs in antimicrobial treatment, with the goals of reducing complications, prolonging catheter retention time, and alleviating patient discomfort.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hangzhou, China, 310016
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure < 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%.
Exclusion Criteria:
- ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: upper arm
①Evaluation: The puncture site was determined by senior nurses based on group assignment before placement.
The depth and diameter of the pre-punctured vein were measured using ultrasound assessment, and the intima of the pre-punctured vein was examined without applying a tourniquet.
②Catheterization: A 3 Fr, 8 cm tip-opened long PIVC was used.
Catheters were placed according to the designated sites for each group using ultrasound-guided and accelerated Seidinger techniques.
After confirming catheter placement, needleless connectors and extension were attached, and the catheter was secured without tension using a sterile transparent dressing.
③Maintenance: Specialized nurses were trained to monitor and evaluate catheter function daily.
Clinical nurses conducted routine maintenance until the study completion.
Daily data were recorded and updated in computerized records.
|
A fixed routine for pre-insertion cleaning and equipment was followed, including hand washing, placing the patient in a recumbent position, skin antisepsis, and preparation of the sterile field.
Catheter insertion was performed by senior specialized nurses in the intravenous treatment room, which was a standardized setting for venipuncture.
|
|
Other: forearm
①Evaluation: The puncture site was determined by senior nurses based on group assignment before placement.
The depth and diameter of the pre-punctured vein were measured using ultrasound assessment, and the intima of the pre-punctured vein was examined without applying a tourniquet.
②Catheterization: A 3 Fr, 8 cm tip-opened long PIVC was used.
Catheters were placed according to the designated sites for each group using ultrasound-guided and accelerated Seidinger techniques.
After confirming catheter placement, needleless connectors and extension were attached, and the catheter was secured without tension using a sterile transparent dressing.
③Maintenance: Specialized nurses were trained to monitor and evaluate catheter function daily.
Clinical nurses conducted routine maintenance until the study completion.
Daily data were recorded and updated in computerized records.
|
A fixed routine for pre-insertion cleaning and equipment was followed, including hand washing, placing the patient in a recumbent position, skin antisepsis, and preparation of the sterile field.
Catheter insertion was performed by senior specialized nurses in the intravenous treatment room, which was a standardized setting for venipuncture.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of catheter-related complications
Time Frame: After insertion of catheter
|
Catheter-related complications were assessed including thrombophlebitis, other phlebitis, catheter occlusion, bleeding, catheter-related infections, and weeping.
|
After insertion of catheter
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Puncture success rate with one-attempt
Time Frame: After insertion of catheter
|
The puncture success rate with one-attempt refers to the instance where the puncture needle successfully enters the target vein on the first attempt without needing to change the puncture site.
|
After insertion of catheter
|
|
The procedure time
Time Frame: After insertion of catheter.
|
The procedure time is defined as the duration from the start of skin disinfection to the stabilization of the catheter with dressing.
|
After insertion of catheter.
|
|
Indwelling catheter duration
Time Frame: After insertion of catheter
|
The Indwelling catheter duration refers to the number of days between the date of catheter placement and its removal.
|
After insertion of catheter
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zhao Linfang, Sir Run Run Shaw Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2024
Primary Completion (Actual)
December 25, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
May 30, 2024
First Submitted That Met QC Criteria
June 6, 2024
First Posted (Actual)
June 12, 2024
Study Record Updates
Last Update Posted (Actual)
April 29, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024-2233-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antimicrobial
-
Fahad RazakCanadian Institutes of Health Research (CIHR); Unity Health Toronto; Sinai Health...Enrolling by invitationAntimicrobial Stewardship | Antimicrobial Drug ResistanceCanada
-
Muhimbili University of Health and Allied SciencesNot yet recruitingAntimicrobial Resistance (AMR) | Antimicrobial Prescribing PracticesTanzania
-
Tan Tock Seng HospitalNational University Hospital, Singapore; Khoo Teck Puat Hospital; Changi General...CompletedAntimicrobial ResistanceSingapore
-
Gama Healthcare Ltd.Completed
-
Nantes University HospitalRecruitingAntimicrobial ResistanceFrance
-
University of OxfordNat Intensive Care Surveillence-MORUNot yet recruitingAntimicrobial Stewardship
-
University of UlsterMerck Sharp & Dohme LLC; Northern Health and Social Care TrustNot yet recruitingAntimicrobial Stewardship
-
Bo YanHangzhou Normal UniversityCompletedAntimicrobial ResistanceChina
-
C. R. BardCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedAntimicrobial ResistanceFrance
Clinical Trials on insert catheter
-
University College DublinLeiden University Medical CenterRecruitingSurfactant | Respiratory Distress Syndrome (RDS) | Respiratory Distress Syndrome (Neonatal) | Video LaryngoscopyNorway, Czech Republic, Poland, Spain, Greece, Croatia, Hungary, Italy, Romania
-
St. Vincent Cardiovascular Research InstituteCompletedAtrial Fibrillation | Catheter Complications | Catheter AblationUnited States
-
Singapore General HospitalRecruitingKnee Osteoarthritis | Degenerative Joint Disease of the KneeSingapore
-
HealthPartners InstituteUniversity of Minnesota; Minnesota Medical FoundationTerminatedKnee OsteoarthritisUnited States
-
Karolinska InstitutetActive, not recruiting
-
Kanuni Sultan Suleyman Training and Research HospitalUnknown
-
Reinier Haga Orthopedisch CentrumRecruitingWear of Articular Bearing Surface of Prosthetic Joint | Migration of ImplantNetherlands
-
Hallux, Inc.CompletedOnychomycosisUnited States
-
Temple UniversityCompletedOcular Hypertension | GlaucomaUnited States
-
University of OklahomaFerring PharmaceuticalsCompletedInduction of Labor | Cervical RipeningUnited States